Literature DB >> 28500603

Fluorescence-Based Binding Assay for Screening Ligands of Angiotensin Receptors.

Maiia E Bragina1, Nikolaos Stergiopulos1, Rodrigo A Fraga-Silva1.   

Abstract

Binding assay is a common technique used to characterize ability of a ligand to interact with a specific biological target. A number of parameters, such as binding affinity, receptor density, and association/dissociation rate constants, can be measured by means of this technique. In most cases, implementation of the binding assay requires specific infrastructure for labeling and detecting the ligand, which impedes realization of this technique in a standard laboratory. Here we describe a simple fluorescence-based binding assay for angiotensin peptides and receptors, which does not require complex equipment and can be used for initial screening of the novel ligands or mutational studies.

Keywords:  Binding assay; Fluorescently labeled; Ligand; Receptor; Renin–angiotensin system; Screening

Mesh:

Substances:

Year:  2017        PMID: 28500603     DOI: 10.1007/978-1-4939-7030-8_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Alterations in renin-angiotensin receptors are not responsible for exercise preconditioning of skeletal muscle fibers.

Authors:  Branden L Nguyen; Toshinori Yoshihara; Rafael Deminice; Jensen Lawrence; Mustafa Ozdemir; Hayden Hyatt; Scott K Powers
Journal:  Sports Med Health Sci       Date:  2021-07-01

2.  Human and Rodent Skeletal Muscles Express Angiotensin II Type 1 Receptors.

Authors:  Rafael Deminice; Hayden Hyatt; Toshinori Yoshihara; Mustafa Ozdemir; Branden Nguyen; Sanford Levine; Scott Powers
Journal:  Cells       Date:  2020-07-14       Impact factor: 6.600

3.  Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models.

Authors:  Lindsay McMurray; Jennifer A Macdonald; Nisha Kuzhuppilly Ramakrishnan; Yanyan Zhao; David W Williamson; Ole Tietz; Xiaoyun Zhou; Steven Kealey; Steven G Fagan; Tomáš Smolek; Veronika Cubinkova; Norbert Žilka; Maria Grazia Spillantini; Aviva M Tolkovsky; Michel Goedert; Franklin I Aigbirhio
Journal:  ACS Chem Neurosci       Date:  2021-03-10       Impact factor: 4.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.